ArticleCardiovascular toxicology2026
Intravenous Mitochondrial Injection Attenuates Methanol-Induced Cardiotoxicity Through Restoration of Mitochondrial Function and Suppression of Oxidative Stress.
Article in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Methanol poisoning induces severe mitochondrial dysfunction through inhibition of mitochondrial respiration, excessive reactive oxygen species (ROS) generation and oxidative stress. The present study investigated whether injection of freshly isolated mitochondria, could attenuate methanol-induced cardiac mitochondrial dysfunction and oxidative damage in rat. Adult male Wistar rats were randomly allocated into five experimental groups: control, methanol, methanol plus single mitochondrial injection, methanol plus repeated mitochondrial injection (double) and mitochondria alone. Fresh functional mitochondria were isolated from healthy donor cardiac tissue and administered intravenously (250 µg/kg), 30 min after methanol intoxication. Serum cardiac injury biomarkers, including creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH), were measured. Oxidative stress was evaluated by determining malondialdehyde (MDA) and glutathione (GSH) levels. Cardiac mitochondrial function was assessed by measuring succinate dehydrogenase (SDH) activity, mitochondrial swelling, mitochondrial ROS production, and mitochondrial membrane potential (MMP). Methanol intoxication significantly increased serum cardiac injury biomarkers, ROS generation, lipid peroxidation, and mitochondrial swelling while markedly reducing GSH content, SDH activity, and MMP compared with the control group. Mitochondrial injection significantly attenuated oxidative stress, decreased ROS production, restored antioxidant capacity, improved SDH activity, reduced mitochondrial swelling, and preserved MMP. Repeated mitochondrial administration showed relatively greater improvement than single administration, although no consistent dose-response relationship was observed. Also, histopathological examinations demonstrated significant recovery following mitochondrial injection. Fresh mitochondrial injection effectively ameliorated methanol-induced cardiotoxicity by reducing oxidative stress, preserving mitochondrial integrity, and restoring mitochondrial function in cardiac tissue. These findings suggest that mitochondrial injection represents a promising mitochondria-targeted therapeutic approach for methanol-induced cardiotoxicity.
Indexed as
Identifiers
42814293What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.